Volume 383, Issue 9930, Pages 1731-1738 (May 2014) Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial Dr Adriana H Tremoulet, MD, Sonia Jain, PhD, Preeti Jaggi, MD, Susan Jimenez-Fernandez, MD, Joan M Pancheri, RN, Xiaoying Sun, MS, John T Kanegaye, MD, John P Kovalchin, MD, Beth F Printz, MD, Prof Octavio Ramilo, MD, Prof Jane C Burns, MD The Lancet Volume 383, Issue 9930, Pages 1731-1738 (May 2014) DOI: 10.1016/S0140-6736(13)62298-9 Copyright © 2014 Elsevier Ltd Terms and Conditions
Figure Trial profile The Lancet 2014 383, 1731-1738DOI: (10.1016/S0140-6736(13)62298-9) Copyright © 2014 Elsevier Ltd Terms and Conditions